1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising prevalences of chronic respiratory diseases
5.2.2. Need for home healthcare devices
5.2.3. Increasing geriatric population with various disease
5.3. Restraints
5.3.1. Side effects of inhalation therapy nebulizer on the health of the consumer
5.4. Opportunities
5.4.1. Use of inhalation therapy nebulizer in other kinds of diseases such as diabetes
5.4.2. Increasing awareness about the inhalation therapy nebulizer with supportive health policies
5.5. Challenges
5.5.1. Less availability of single effective inhaler devices

6. Inhalation Therapy Nebulizer Market, by Type
6.1. Introduction
6.2. Atomizer Jet
6.3. Ultrasonic Nebulizers

7. Inhalation Therapy Nebulizer Market, by Application
7.1. Introduction
7.2. Asthma
7.3. Chronic Obstructive Pulmonary Disease (COPD)
7.4. Cystic Fibrosis
7.5. Nasal Congestion

8. Inhalation Therapy Nebulizer Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Home Care Centers
8.4. Hospitals

9. Americas Inhalation Therapy Nebulizer Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Inhalation Therapy Nebulizer Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Inhalation Therapy Nebulizer Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. A&D Company
13.2. Air Liquide Medical Systems
13.3. AptarGroup, Inc.
13.4. Boehringer Ingelheim International GmbH
13.5. DeVilbiss Healthcare LLC
13.6. GF HEALTH PRODUCTS, INC.
13.7. Koninklijke Philips N.V.
13.8. M
13.9. OMRON Corporation
13.10. PARI GmbH Spezialisten für effektive Inhalation
13.11. Trudell Medical International
13.12. Vyaire Medical Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL INHALATION THERAPY NEBULIZER MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2026
FIGURE 7. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ATOMIZER JET, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ATOMIZER JET, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ULTRASONIC NEBULIZERS, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 12. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2026
FIGURE 14. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ASTHMA, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ASTHMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY NASAL CONGESTION, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY NASAL CONGESTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 23. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2026
FIGURE 25. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOME CARE CENTERS, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOME CARE CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL INHALATION THERAPY NEBULIZER MARKET: FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL INHALATION THERAPY NEBULIZER MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INHALATION THERAPY NEBULIZER MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL INHALATION THERAPY NEBULIZER MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ATOMIZER JET, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY ASTHMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY NASAL CONGESTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOME CARE CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL INHALATION THERAPY NEBULIZER MARKET: SCORES
TABLE 47. GLOBAL INHALATION THERAPY NEBULIZER MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL INHALATION THERAPY NEBULIZER MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL INHALATION THERAPY NEBULIZER MARKET: RANKING
TABLE 50. GLOBAL INHALATION THERAPY NEBULIZER MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL INHALATION THERAPY NEBULIZER MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL INHALATION THERAPY NEBULIZER MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL INHALATION THERAPY NEBULIZER MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL INHALATION THERAPY NEBULIZER MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL INHALATION THERAPY NEBULIZER MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL INHALATION THERAPY NEBULIZER MARKET: LICENSE & PRICING

Companies Mentioned

A&D Company
Air Liquide Medical Systems
AptarGroup, Inc.
Boehringer Ingelheim International GmbH
DeVilbiss Healthcare LLC
GF HEALTH PRODUCTS, INC.
Koninklijke Philips N.V.
M
OMRON Corporation
PARI GmbH Spezialisten für effektive Inhalation
Trudell Medical International
Vyaire Medical Inc.